We also observed a certain degree of tumor promotion in the PP2A cKO mouse group treated with the inhibitor, suggesting that inhibition of PP2A on tumor promotion is not limited to CD8+ T cells (Fig. 6B to E and Fig. S6B and C). The gene discussed is PTPA; the disease is neoplasm.